Welcome to the Future of Surgery

The Commission on the Future of Surgery gazed twenty years into the future to identify advances in medicine and technology that are likely to change surgical care. We analysed evidence and assessed the implications of such developments for patients, the surgical profession and the healthcare system.

This is an exciting time to be involved in surgery. The future of surgery will bring innovative technologies, enhanced understanding of disease and wider collaboration among experts and innovators to improve patient care. The partnership between patients and clinicians will remain at the centre of healthcare.

Technologies such as surgical robots, artificial intelligence, three-dimensional printing and new imaging methods are already changing and will continue to change the way surgical care is delivered. Developments in fields such as genomics, regenerative medicine and cell-based therapies could open new avenues for predicting and treating disease, which were unthinkable only a few years ago.

Explore what the future looks like, which technologies are likely to have the greatest impact, and what this means for patients and surgical professionals.

WHICH TECHNOLOGIES WILL MAKE THE GREATEST IMPACT?

Surgery will be transformed over the next two decades. Four groups of technological developments are likely to make the greatest impact.

WHAT DOES THE FUTURE
MEAN FOR PATIENTS?

Surgery is currently used to treat advanced disease and takes place after the display of symptoms. In the future, surgery will potentially prevent – and not just treat – illness.

Healthcare will continue to shift towards establishing and maintaining good health, prevention and prediction of disease, early intervention and co-ordinated management of chronic conditions.

Patients can confidently expect surgery to become gradually less invasive, more accurate, have more predictable outcomes, faster recovery times and lower risk of harm.

The current unique relationship between the patient and the surgical team will become even more important, as technology allows greater access to information.

Surgery is likely to increasingly focus on improving quality of life and operating on well people and older patients with the aim of prevention.

New drugs and the development of other non-invasive treatments may make surgery obsolete for some conditions. Advances in radiotherapy and immunotherapy may drastically reduce the need for cancer surgery. Vaccination programmes are likely to affect the incidence of virally-driven diseases, such as the vaccination against human papillomavirus to prevent cervical, anal and oral cancer.

Less invasive technologies and advances in imaging will enable more patients, particularly frail and older people, and more diseases to be treated with surgery. For example, functional imaging of the brain is already enabling more radical but safer micro-surgery for some cerebral tumours.

The Commission does not anticipate any radical increases to life expectancy unless a significant breakthrough revolutionises prevention of the main causes of mortality. Societal attitudes to conditions like obesity might influence future longevity.

Patients will continue to experience an increasing burden of non-communicable chronic diseases and multiple morbidities, such as diabetes or dementia.

The ubiquity of healthcare information and personal data may help patients to become more informed about their own health, but may also lead to greater anxiety. For example, genomic information may inflate demand for risk-reducing surgery.

The speed and variety of innovations and information available will be such that patients may need specialist advice and support to make decisions about their care. For example, greater access to data and medical knowledge may generate inequalities due to different levels of health literacy.

CASE STUDY
MyRecovery.AI

View Case Study

CASE STUDY
AI Command Centre – Bradford Teaching Hospitals NHS Foundation Trust

View Case Study

3D printers used as training tools for surgeons at Alder Hey Innovation Hub. Image credit Alder Hey Children's Hospital NHS Foundation Trust
3D printers used as training tools for surgeons at Alder Hey Innovation Hub. Image credit Alder Hey Children’s Hospital NHS Foundation Trust

HOW WILL THE DELIVERY
OF SURGERY CHANGE?

Operating theatres are likely to look different with greater integration of digital technologies. In the long-term, AI could be used to schedule procedures, request instruments and monitor the environment. Digital systems will also provide guidance to the operating team and show enhanced anatomical imaging.

Theatre space will become more flexible and dynamic, as equipment will be smaller and lighter.

The recent history of complex surgery has been one of increasing centralisation to improve treatment results for patients by concentrating expertise and resources to make services more sustainable.

Specialised treatments – such as stem cell therapies or tissue engineering – will continue to be delivered by multidisciplinary teams with specialist expertise. Such care will only be available in a small number of locations, which need to be carefully planned. Other digital technologies, such as 3D printing and planning, will also benefit from multidisciplinary hubs.

Digital technologies and robotics could enable more types of routine surgery to be delivered locally if resources are available, thanks to platforms allowing for remote support and proctoring, and robotic platforms of smaller size and greater versatility.

As the ageing population is expected to live increasingly outside of metropolitan areas, demand for care in those areas will also grow. The current trend of an increasing amount of day-case and overnight stay surgery will continue. Preoperative and follow-up assessment will therefore acquire even greater importance, but they are likely to be undertaken in local settings through the use of telemedicine and digital platforms.

In contrast to drugs, many surgical innovations are introduced without clinical trial data or centrally held evidence. This is a risk to patient safety and public confidence.

Pathways need to be developed to assess digital devices, diagnostics and drugs, with compulsory registration of novel technologies and devices, using real-time data. A ‘one size fits all’ approach for randomised control trials or a national registry will not work for all innovations.

The surgical royal colleges could have a role in working with national regulators to support or oversee registries of innovations, and support the uptake of innovations that improve quality of life and patient safety.

Submission of follow-up information to central databases is crucial to ensure patient safety. A framework should be in place to oversee this, comprised of appropriate regulators who have access to databases.

THE FUTURE
SURGICAL TEAM

The future of surgery is exciting and full of change, and it will continue to need to attract talented, innovative and compassionate individuals.

The multi-disciplinary and multi-professional surgical care team will become increasingly important in developing and delivering care of the highest quality. They will be able to provide more aspects of care and may take over some areas of surgical care currently delivered by surgeons.

Specialised treatments will give rise to increased multi-disciplinary working. Surgical teams will work alongside bioengineers, geneticists, molecular biologists, data-analysts, transplantation experts and other expert disciplines.

The evolution of the role of the surgeon is likely to depend on the best treatment option for the patient. It could remain unchanged for areas little affected by developments in alternative treatment options or become increasingly blurred with the role of other clinicians for areas where other types of treatments may become preferable.

The surgeon’s role will become increasingly multifaceted and surgeons will need to become ‘multi-linguists’, understanding the language of medicine, genetics, surgery, radiotherapy and bioengineering.

The content of the surgical training curriculum will need to change and be flexible to reflect the likely future career of a surgeon and innovations as they evolve. With flexibility will come options to be a clinical surgeon, scientist, entrepreneur, educator, innovator or manager, with the ability to move across different roles throughout a career.

Training must incorporate knowledge of computing, engineering, molecular biology, data literacy, leadership, team building and communication. In an increasingly digitised health service, we must strive to ensure and enhance the humanity in surgery.

New technologies such as data analytics, AR and VR will enhance training, with high-fidelity patient-specific simulation, and remote mentoring and proctoring.

Entry requirements for medical school will need to reflect the diverse range of skills required and encourage students from other backgrounds, such as engineering or computing, to enter medicine.